Targeting miR29b in a Porcine Model of Aortic Aneurysm Disease: A Novel Endovascular Treatment Option

• K. Hanft,
• S. Metschl,
• H. Winter,
• J. Pauli,
• N. Sachs,
• R. Boon,
• S. Dimmeler,
• C. Knappich,
• A. Busch,
• L. Mägdefessel

Affiliations

K. Hanft

Institute for Molecular and Vascular Medicine, University Hospital Rechts der Isar, Munich, Germany, Munich, Germany

S. Metschl

Institute for Molecular and Vascular Medicine, University Hospital Rechts der Isar, Munich, Germany, Munich, Germany

H. Winter

Institute for Molecular and Vascular Medicine, University Hospital Rechts der Isar, Munich, Germany, Munich, Germany

J. Pauli

Institute for Molecular and Vascular Medicine, University Hospital Rechts der Isar, Munich, Germany, Munich, Germany

N. Sachs

Department for Vascular and Endovascular Surgery, University Hospital Rechts der Isar, Germany, Munich, Germany

R. Boon

Institute for Cardiovascular Regeneration, Goethe University Frankfurt, Germany, Frankfurt, Germany

S. Dimmeler

Institute for Cardiovascular Regeneration, Goethe University Frankfurt, Germany, Frankfurt, Germany

C. Knappich

Department for Vascular and Endovascular Surgery, University Hospital Rechts der Isar, Germany, Munich, Germany

A. Busch

Department for Vascular Surgery, University Hospital Carl Gustav Carus, Dresden, Germany, Dresden, Germany

L. Mägdefessel

Institute for Molecular and Vascular Medicine, University Hospital Rechts der Isar, Munich, Germany, Munich, Germany